Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1998 May-Jun:(3):40-3.

[Evaluation of the effectiveness of influenza trivalent polymer subunit vaccine "Grippol"]

[Article in Russian]
G A El'shina  1 , M A Gorbunov, V I Shervarli, N I Lonskaia, L I Pavlova, R M Khaitov, A V Nekrasov, A S Ivanova, M N Matrosovich, N G Puchkova, V P Belashev, A A Malinovskiĭ
Affiliations
  • PMID: 9700880
Clinical Trial

[Evaluation of the effectiveness of influenza trivalent polymer subunit vaccine "Grippol"]

[Article in Russian]
G A El'shina et al. Zh Mikrobiol Epidemiol Immunobiol. 1998 May-Jun.

Abstract

Influenza polymer-subunit vaccine "Grippol", made up of the sterile conjugate of surface proteins of influenza viruses, groups A and B, with polyoxidonium (copolymer), was obtained at the State Scientific Centre of Research Institute of Immunology. As the result of our investigations, the coefficient of prophylactic effectiveness of vaccine "Grippol" was found to be 71%; in the presence of the 50% immune stratum in the group the coefficient of antiepidemic protection was found to be 66.4%. At the same time, cases of influenza and acute respiratory diseases were shown to take a milder form in persons immunized with vaccine "Grippol" than in the group of nonimmunized subjects. The results of this investigation did not show any side effects caused by the vaccine.

PubMed Disclaimer

Substances

LinkOut - more resources